KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Amortization of Deferred Charges (2016 - 2019)

Medpace Holdings (MEDP) has disclosed Amortization of Deferred Charges for 5 consecutive years, with $200000.0 as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, Amortization of Deferred Charges rose 29.87% year-over-year to $200000.0, compared with a TTM value of $200000.0 through Jun 2020, down 82.94%, and an annual FY2019 reading of $954000.0, up 55.12% over the prior year.
  • Amortization of Deferred Charges was $200000.0 for Q3 2019 at Medpace Holdings, down from $736000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $736000.0 in Q2 2019 and bottomed at $138000.0 in Q1 2019.
  • Average Amortization of Deferred Charges over 5 years is $350375.0, with a median of $166500.0 recorded in 2017.
  • The sharpest move saw Amortization of Deferred Charges crashed 75.55% in 2017, then surged 365.82% in 2019.
  • Year by year, Amortization of Deferred Charges stood at $679000.0 in 2015, then decreased by 18.7% to $552000.0 in 2016, then plummeted by 70.29% to $164000.0 in 2017, then fell by 12.2% to $144000.0 in 2018, then skyrocketed by 38.89% to $200000.0 in 2019.
  • Business Quant data shows Amortization of Deferred Charges for MEDP at $200000.0 in Q3 2019, $736000.0 in Q2 2019, and $138000.0 in Q1 2019.